301 related articles for article (PubMed ID: 7796869)
21. Opioid antagonist profile of SC nor-binaltorphimine in the formalin paw assay.
Wettstein JG; Grouhel A
Pharmacol Biochem Behav; 1996 Feb; 53(2):411-6. PubMed ID: 8808151
[TBL] [Abstract][Full Text] [Related]
22. Differential effects of mu-, delta- and kappa-opioid receptor agonists on the discriminative stimulus properties of cocaine in rats.
Suzuki T; Mori T; Tsuji M; Maeda J; Kishimoto Y; Misawa M; Nagase H
Eur J Pharmacol; 1997 Apr; 324(1):21-9. PubMed ID: 9137909
[TBL] [Abstract][Full Text] [Related]
23. Roles of mu, delta and kappa opioid receptors in spinal and supraspinal mediation of gastrointestinal transit effects and hot-plate analgesia in the mouse.
Porreca F; Mosberg HI; Hurst R; Hruby VJ; Burks TF
J Pharmacol Exp Ther; 1984 Aug; 230(2):341-8. PubMed ID: 6086883
[TBL] [Abstract][Full Text] [Related]
24. Role of L-type Ca(2+) channels in pertussis toxin induced antagonism of U50,488H analgesia and hypothermia.
Gullapalli S; Ramarao P
Brain Res; 2002 Aug; 946(2):191-7. PubMed ID: 12137921
[TBL] [Abstract][Full Text] [Related]
25. Antidiarrheal properties of supraspinal mu and delta and peripheral mu, delta and kappa opioid receptors: inhibition of diarrhea without constipation.
Shook JE; Lemcke PK; Gehrig CA; Hruby VJ; Burks TF
J Pharmacol Exp Ther; 1989 Apr; 249(1):83-90. PubMed ID: 2540324
[TBL] [Abstract][Full Text] [Related]
26. kappa-Opioid receptor agonists improve pirenzepine-induced disturbance of spontaneous alternation performance in the mouse.
Ukai M; Shinkai N; Kameyama T
Eur J Pharmacol; 1995 Aug; 281(2):173-8. PubMed ID: 7589204
[TBL] [Abstract][Full Text] [Related]
27. Pertussis toxin, but not tyrosine kinase inhibitors, abolishes effects of U-50488H on [Ca2+]i in myocytes.
Sheng JZ; Wong NS; Wang HX; Wong TM
Am J Physiol; 1997 Feb; 272(2 Pt 1):C560-4. PubMed ID: 9124299
[TBL] [Abstract][Full Text] [Related]
28. Functional effects of systemically administered agonists and antagonists of mu, delta, and kappa opioid receptor subtypes on body temperature in mice.
Baker AK; Meert TF
J Pharmacol Exp Ther; 2002 Sep; 302(3):1253-64. PubMed ID: 12183687
[TBL] [Abstract][Full Text] [Related]
29. Tonic pain perception in the mouse: differential modulation by three receptor-selective opioid agonists.
Murray CW; Cowan A
J Pharmacol Exp Ther; 1991 Apr; 257(1):335-41. PubMed ID: 1850470
[TBL] [Abstract][Full Text] [Related]
30. Different motor actions of dynorphins and nonpeptide kappa opioid receptor agonists in the isolated rat colon.
Scheurer U; Wenger F; Caliezi A; Drack E; Varga L; Halter F
J Pharmacol Exp Ther; 1990 Mar; 252(3):1324-30. PubMed ID: 1969475
[TBL] [Abstract][Full Text] [Related]
31. Streptozotocin-induced diabetes selectively alters the potency of analgesia produced by mu-opioid agonists, but not by delta- and kappa-opioid agonists.
Kamei J; Ohhashi Y; Aoki T; Kawasima N; Kasuya Y
Brain Res; 1992 Feb; 571(2):199-203. PubMed ID: 1319265
[TBL] [Abstract][Full Text] [Related]
32. Majonoside-R2, a major constituent of Vietnamese ginseng, attenuates opioid-induced antinociception.
Huong NT; Matsumoto K; Yamasaki K; Duc NM; Nham NT; Watanabe H
Pharmacol Biochem Behav; 1997; 57(1-2):285-91. PubMed ID: 9164584
[TBL] [Abstract][Full Text] [Related]
33. Evidence for a metabostatic opioid kappa-receptor inhibiting pertussis toxin-sensitive metabotropic glutamate receptor-currents in Xenopus oocytes.
Ueda H; Miyamae T; Fukushima N; Watanabe S; Misu Y
FEBS Lett; 1995 Nov; 375(3):201-5. PubMed ID: 7498499
[TBL] [Abstract][Full Text] [Related]
34. Effects of kappa- and mu-selective opiate agonists on colonic temperature in normoglycaemic and streptozotocin-treated hyperglycaemic mice.
Bansinath M; Ramabadran K; Turndorf H; Puig MM
Pharmacol Toxicol; 1990 May; 66(5):324-8. PubMed ID: 2164667
[TBL] [Abstract][Full Text] [Related]
35. Development of behavioral sensitization to cocaine: influence of kappa opioid receptor agonists.
Heidbreder CA; Babovic-Vuksanovic D; Shoaib M; Shippenberg TS
J Pharmacol Exp Ther; 1995 Oct; 275(1):150-63. PubMed ID: 7562544
[TBL] [Abstract][Full Text] [Related]
36. kappa-Opioid receptor-transfected cell lines: modulation of adenylyl cyclase activity following acute and chronic opioid treatments.
Avidor-Reiss T; Zippel R; Levy R; Saya D; Ezra V; Barg J; Matus-Leibovitch N; Vogel Z
FEBS Lett; 1995 Mar; 361(1):70-4. PubMed ID: 7890042
[TBL] [Abstract][Full Text] [Related]
37. Probes for narcotic receptor mediated phenomena. 17. Synthesis and evaluation of a series of trans-3,4-dichloro-N-methyl-N-[2-(1-pyrrolidinyl)cyclohexyl]benzeneacet amide (U50,488) related isothiocyanate derivatives as opioid receptor affinity ligands.
de Costa BR; Rothman RB; Bykov V; Band L; Pert A; Jacobson AE; Rice KC
J Med Chem; 1990 Apr; 33(4):1171-6. PubMed ID: 2157008
[TBL] [Abstract][Full Text] [Related]
38. Lack of effect of kappa-opioid receptor agonism on long-term methamphetamine-induced neurotoxicity in rats.
Johnson-Davis KL; Hanson GR; Keefe KA
Neurotox Res; 2003; 5(4):273-81. PubMed ID: 12835119
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of L-type calcium currents in guinea pig ventricular myocytes by the kappa-opioid agonist U50488H does not involve binding to opiate receptors.
Utz J; Eckert R; Trautwein W
J Pharmacol Exp Ther; 1995 Aug; 274(2):627-33. PubMed ID: 7543570
[TBL] [Abstract][Full Text] [Related]
40. Central kappa opioid receptor-evoked changes in renal function in conscious rats: participation of renal nerves.
Kapusta DR; Obih JC
J Pharmacol Exp Ther; 1993 Oct; 267(1):197-204. PubMed ID: 8229746
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
